Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
124.35 SEK | -1.62% |
|
-4.05% | +17.76% |
02-06 | Goldman Sachs raises target price for Hexagon to SEK 105 (95), reiterates sell - BN | FW |
02-05 | Earnings consensus raised for Hexagon after report | FW |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3.91B | 3.76B | 4.34B | 5.16B | 5.44B | |||||
Total Revenues | 3.91B | 3.76B | 4.34B | 5.16B | 5.44B | |||||
Cost of Goods Sold, Total | 1.44B | 1.38B | 1.54B | 1.79B | 1.89B | |||||
Gross Profit | 2.47B | 2.38B | 2.8B | 3.37B | 3.54B | |||||
Selling General & Admin Expenses, Total | 1.06B | 985M | 1.11B | 1.36B | 1.64B | |||||
R&D Expenses | 431M | 458M | 456M | 516M | 674M | |||||
Other Operating Expenses | -12.2M | -69.3M | -64.6M | 7M | -22.6M | |||||
Other Operating Expenses, Total | 1.48B | 1.37B | 1.5B | 1.89B | 2.29B | |||||
Operating Income | 987M | 1.01B | 1.3B | 1.48B | 1.25B | |||||
Interest Expense, Total | -22.9M | -23.3M | -19.1M | -34.9M | -153M | |||||
Interest And Investment Income | 6.2M | 5.7M | 4.4M | 7.6M | 12.4M | |||||
Net Interest Expenses | -16.7M | -17.6M | -14.7M | -27.3M | -140M | |||||
Income (Loss) On Equity Invest. | - | - | - | - | - | |||||
Currency Exchange Gains (Loss) | -6.3M | -17.6M | 8.3M | -4.1M | -23.9M | |||||
Other Non Operating Income (Expenses) | -9.4M | -9.6M | -10.8M | -10.7M | -13.6M | |||||
EBT, Excl. Unusual Items | 955M | 964M | 1.28B | 1.44B | 1.07B | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | -8.5M | -15.6M | -31.2M | -10M | -8.2M | |||||
Impairment of Goodwill | - | -8.5M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | -500K | 400K | 10.4M | 3.8M | 10.2M | |||||
Asset Writedown | -25.6M | -137M | -173M | -13.4M | -54.5M | |||||
Other Unusual Items | -54.9M | -44.4M | -100M | -172M | 41.6M | |||||
EBT, Incl. Unusual Items | 865M | 760M | 984M | 1.25B | 1.06B | |||||
Income Tax Expense | 157M | 135M | 174M | 229M | 189M | |||||
Earnings From Continuing Operations | 709M | 625M | 810M | 1.02B | 872M | |||||
Net Income to Company | 709M | 625M | 810M | 1.02B | 872M | |||||
Minority Interest | -6.2M | -6.6M | -8.4M | -11.5M | -12.9M | |||||
Net Income - (IS) | 702M | 618M | 802M | 1.01B | 859M | |||||
Net Income to Common Incl Extra Items | 702M | 618M | 802M | 1.01B | 859M | |||||
Net Income to Common Excl. Extra Items | 702M | 618M | 802M | 1.01B | 859M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.27 | 0.24 | 0.31 | 0.37 | 0.32 | |||||
Basic EPS - Continuing Operations | 0.27 | 0.24 | 0.31 | 0.37 | 0.32 | |||||
Basic Weighted Average Shares Outstanding | 2.55B | 2.57B | 2.6B | 2.69B | 2.69B | |||||
Net EPS - Diluted | 0.27 | 0.24 | 0.31 | 0.37 | 0.32 | |||||
Diluted EPS - Continuing Operations | 0.27 | 0.24 | 0.31 | 0.37 | 0.32 | |||||
Diluted Weighted Average Shares Outstanding | 2.56B | 2.57B | 2.61B | 2.71B | 2.71B | |||||
Normalized Basic EPS | 0.23 | 0.23 | 0.3 | 0.33 | 0.24 | |||||
Normalized Diluted EPS | 0.23 | 0.23 | 0.3 | 0.33 | 0.24 | |||||
Dividend Per Share | 0.09 | 0.09 | 0.11 | 0.12 | 0.13 | |||||
Payout Ratio | 30.69 | 36.87 | 29.74 | 29.36 | 37.58 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.12B | 1.16B | 1.45B | 1.69B | 1.48B | |||||
EBITA | 1.05B | 1.07B | 1.37B | 1.6B | 1.38B | |||||
EBIT | 987M | 1.01B | 1.3B | 1.48B | 1.25B | |||||
EBITDAR | 1.13B | 1.16B | 1.45B | 1.69B | - | |||||
Effective Tax Rate - (Ratio) | 18.11 | 17.76 | 17.65 | 18.34 | 17.81 | |||||
Total Current Taxes | 180M | 145M | 208M | 256M | 207M | |||||
Total Deferred Taxes | -23.1M | -9.8M | -34.7M | -26.6M | -17.8M | |||||
Normalized Net Income | 591M | 596M | 790M | 889M | 657M | |||||
Interest on Long-Term Debt | 8.8M | 8M | 7.6M | 7.9M | 8.3M | |||||
Non-Cash Pension Expense | 1.4M | 300K | 600K | 800K | -600K | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 749M | 674M | 766M | 968M | 1.16B | |||||
General and Administrative Expenses | 311M | 310M | 346M | 396M | 481M | |||||
Research And Development Expense From Footnotes | 470M | 562M | 665M | 781M | 880M | |||||
Net Rental Expense, Total | 2.1M | 500K | 500K | 500K | - | |||||
Imputed Operating Lease Interest Expense | 159K | 36.3K | 27.35K | 40.98K | - | |||||
Imputed Operating Lease Depreciation | 1.94M | 464K | 473K | 459K | - | |||||
Stock-Based Comp., Other (Total) | - | - | 25.1M | 40.5M | 61.4M | |||||
Total Stock-Based Compensation | - | - | 25.1M | 40.5M | 61.4M |